Review



anti-slt2 sc-374434  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Santa Cruz Biotechnology anti-slt2 sc-374434
    Anti Slt2 Sc 374434, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-slt2 sc-374434/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    anti-slt2 sc-374434 - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    90
    AstraZeneca ltd slt2 inhibitor meeting
    Slt2 Inhibitor Meeting, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/slt2 inhibitor meeting/product/AstraZeneca ltd
    Average 90 stars, based on 1 article reviews
    slt2 inhibitor meeting - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc anti-phospho-slt2
    Anti Phospho Slt2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-phospho-slt2/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    anti-phospho-slt2 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology anti-slt2 sc-374434
    Anti Slt2 Sc 374434, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-slt2 sc-374434/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    anti-slt2 sc-374434 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc anti-slt2 p44/42 mapk (erk1/2
    Anti Slt2 P44/42 Mapk (Erk1/2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-slt2 p44/42 mapk (erk1/2/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    anti-slt2 p44/42 mapk (erk1/2 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology slt2-specific antibody antimpk1
    Slt2 Specific Antibody Antimpk1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/slt2-specific antibody antimpk1/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    slt2-specific antibody antimpk1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc anti-phospho-slt2 phospho-p44/42 mapk (erk1/2) antibody
    Anti Phospho Slt2 Phospho P44/42 Mapk (Erk1/2) Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-phospho-slt2 phospho-p44/42 mapk (erk1/2) antibody/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    anti-phospho-slt2 phospho-p44/42 mapk (erk1/2) antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology slt2-specific antibody anti-mpk1
    Slt2 Specific Antibody Anti Mpk1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/slt2-specific antibody anti-mpk1/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    slt2-specific antibody anti-mpk1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc 2023 antibodies against phospho slt2
    Figure 4. cof1-5 mutation triggers activation of the CWI pathway (A and B) Immunoblots detecting <t>Slt2</t> phosphorylation when grown on glucose and glycerol containing media are shown in A and B, respectively. (C) Pkc1 inhibition by cercosporamide (CSA) administration prevented Slt2 phosphorylation. (D) Porin deletion and overexpression reveal dependence of Slt2 phosphorylation on Por1. (E) cof1-5 mutation triggers loss of plasma membrane integrity, as assessed flow cytometrically with PI positivity at 48 h after inoculation. PI positivity is exacerbated by additional Pkc1 inhibition using the Pkc1-inhibitor cercosporamide or applying additional cell wall stress with calcofluor white (CFW). Combined treatment with CSA and CFW at the same time shows additive effects. (F) POR1 deletion rescues from cof1-5-dependent loss of viability and loss of plasma membrane integrity, whereas SLT2 deletion sensitises to cell death. (G–J) Chronological aging analysis reveals shortening of chronological lifespan in cof1-5 cells which depends on POR1. Colony forming unit formation based on clonogenic survival is depicted in G and H, whereas PI positivity is shown in I and J. Statistical significance in E, F, H, and J was assessed using Brown-Forsythe and Welch-ANOVA test. Asterisks indicate significance based on p-levels of the comparisons to the respective control strains. See also Figure S2. Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
    2023 Antibodies Against Phospho Slt2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/2023 antibodies against phospho slt2/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    2023 antibodies against phospho slt2 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    94
    Addgene inc virus strains pyx122 mtgfp b westermann71 pcg44 prs426 slt2 gfp matthias peter35 ppr a75 pag418 por1
    Figure 4. cof1-5 mutation triggers activation of the CWI pathway (A and B) Immunoblots detecting <t>Slt2</t> phosphorylation when grown on glucose and glycerol containing media are shown in A and B, respectively. (C) Pkc1 inhibition by cercosporamide (CSA) administration prevented Slt2 phosphorylation. (D) Porin deletion and overexpression reveal dependence of Slt2 phosphorylation on Por1. (E) cof1-5 mutation triggers loss of plasma membrane integrity, as assessed flow cytometrically with PI positivity at 48 h after inoculation. PI positivity is exacerbated by additional Pkc1 inhibition using the Pkc1-inhibitor cercosporamide or applying additional cell wall stress with calcofluor white (CFW). Combined treatment with CSA and CFW at the same time shows additive effects. (F) POR1 deletion rescues from cof1-5-dependent loss of viability and loss of plasma membrane integrity, whereas SLT2 deletion sensitises to cell death. (G–J) Chronological aging analysis reveals shortening of chronological lifespan in cof1-5 cells which depends on POR1. Colony forming unit formation based on clonogenic survival is depicted in G and H, whereas PI positivity is shown in I and J. Statistical significance in E, F, H, and J was assessed using Brown-Forsythe and Welch-ANOVA test. Asterisks indicate significance based on p-levels of the comparisons to the respective control strains. See also Figure S2. Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
    Virus Strains Pyx122 Mtgfp B Westermann71 Pcg44 Prs426 Slt2 Gfp Matthias Peter35 Ppr A75 Pag418 Por1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/virus strains pyx122 mtgfp b westermann71 pcg44 prs426 slt2 gfp matthias peter35 ppr a75 pag418 por1/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    virus strains pyx122 mtgfp b westermann71 pcg44 prs426 slt2 gfp matthias peter35 ppr a75 pag418 por1 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc antibodies against phospho slt2
    cof1-5 mutation triggers activation of the CWI pathway (A and B) Immunoblots detecting <t>Slt2</t> phosphorylation when grown on glucose and glycerol containing media are shown in A and B, respectively. (C) Pkc1 inhibition by cercosporamide (CSA) administration prevented Slt2 phosphorylation. (D) Porin deletion and overexpression reveal dependence of Slt2 phosphorylation on Por1. (E) cof1-5 mutation triggers loss of plasma membrane integrity, as assessed flow cytometrically with PI positivity at 48 h after inoculation. PI positivity is exacerbated by additional Pkc1 inhibition using the Pkc1-inhibitor cercosporamide or applying additional cell wall stress with calcofluor white (CFW). Combined treatment with CSA and CFW at the same time shows additive effects. (F) POR1 deletion rescues from cof1-5 -dependent loss of viability and loss of plasma membrane integrity, whereas SLT2 deletion sensitises to cell death. (G–J) Chronological aging analysis reveals shortening of chronological lifespan in cof1-5 cells which depends on POR1 . Colony forming unit formation based on clonogenic survival is depicted in G and H, whereas PI positivity is shown in I and J. Statistical significance in E, F, H, and J was assessed using Brown-Forsythe and Welch-ANOVA test. Asterisks indicate significance based on p-levels of the comparisons to the respective control strains. See also <xref ref-type=Figure S2 . Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. " width="250" height="auto" />
    Antibodies Against Phospho Slt2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against phospho slt2/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    antibodies against phospho slt2 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    Image Search Results


    Figure 4. cof1-5 mutation triggers activation of the CWI pathway (A and B) Immunoblots detecting Slt2 phosphorylation when grown on glucose and glycerol containing media are shown in A and B, respectively. (C) Pkc1 inhibition by cercosporamide (CSA) administration prevented Slt2 phosphorylation. (D) Porin deletion and overexpression reveal dependence of Slt2 phosphorylation on Por1. (E) cof1-5 mutation triggers loss of plasma membrane integrity, as assessed flow cytometrically with PI positivity at 48 h after inoculation. PI positivity is exacerbated by additional Pkc1 inhibition using the Pkc1-inhibitor cercosporamide or applying additional cell wall stress with calcofluor white (CFW). Combined treatment with CSA and CFW at the same time shows additive effects. (F) POR1 deletion rescues from cof1-5-dependent loss of viability and loss of plasma membrane integrity, whereas SLT2 deletion sensitises to cell death. (G–J) Chronological aging analysis reveals shortening of chronological lifespan in cof1-5 cells which depends on POR1. Colony forming unit formation based on clonogenic survival is depicted in G and H, whereas PI positivity is shown in I and J. Statistical significance in E, F, H, and J was assessed using Brown-Forsythe and Welch-ANOVA test. Asterisks indicate significance based on p-levels of the comparisons to the respective control strains. See also Figure S2. Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

    Journal: iScience

    Article Title: A dynamic actin cytoskeleton is required to prevent constitutive VDAC-dependent MAPK signalling and aberrant lipid homeostasis.

    doi: 10.1016/j.isci.2023.107539

    Figure Lengend Snippet: Figure 4. cof1-5 mutation triggers activation of the CWI pathway (A and B) Immunoblots detecting Slt2 phosphorylation when grown on glucose and glycerol containing media are shown in A and B, respectively. (C) Pkc1 inhibition by cercosporamide (CSA) administration prevented Slt2 phosphorylation. (D) Porin deletion and overexpression reveal dependence of Slt2 phosphorylation on Por1. (E) cof1-5 mutation triggers loss of plasma membrane integrity, as assessed flow cytometrically with PI positivity at 48 h after inoculation. PI positivity is exacerbated by additional Pkc1 inhibition using the Pkc1-inhibitor cercosporamide or applying additional cell wall stress with calcofluor white (CFW). Combined treatment with CSA and CFW at the same time shows additive effects. (F) POR1 deletion rescues from cof1-5-dependent loss of viability and loss of plasma membrane integrity, whereas SLT2 deletion sensitises to cell death. (G–J) Chronological aging analysis reveals shortening of chronological lifespan in cof1-5 cells which depends on POR1. Colony forming unit formation based on clonogenic survival is depicted in G and H, whereas PI positivity is shown in I and J. Statistical significance in E, F, H, and J was assessed using Brown-Forsythe and Welch-ANOVA test. Asterisks indicate significance based on p-levels of the comparisons to the respective control strains. See also Figure S2. Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

    Article Snippet: Immunoblotting followed standard procedures, with transfer of proteins to a 0.45 mm nitrocellulose membrane and probing with 24 iScience 26, 107539, September 15, 2023 antibodies against phospho-Slt2 (Phospho-p44/42 MAPK, cell signaling, #9101, 1:1000), actin (a-Yeast act1 Goat monoclonal antibody, a kind gift from Prof. John Cooper, Washington University, 1:2000), (glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Life Technologies, MA515738, 1:5000), or VDAC/porin (Abcam, ab110326, 1:5000).

    Techniques: Mutagenesis, Activation Assay, Western Blot, Phospho-proteomics, Inhibition, Over Expression, Clinical Proteomics, Membrane, Control

    Figure 5. Slt2 localisation to the mitochondrial compartment is enhanced in cof1-5 cells (A) Slt2, which is mostly found in the nucleus in wild-type cells at stationary phase, forms punctate foci in cof1-5, as documented by fluorescence microscopy using chromosomally tagged SLT2-GFP under control of its endogenous promoter. Deconvolved pictures with Hoechst staining for nuclei are shown. (B and C) Cells showing nuclear localisation of Slt2-GFP (B) and foci-forming cells (C) were quantified, plotted and analyzed for significant localisation change as compared to wild type. (D) Representative fluorescence microscopy pictures of Slt2-GFP expressing cells with rhodamine B hexylester staining for colocalization analysis with mitochondria. (E) Colocalisation of Slt2-GFP (green) with the mitochondrial stain rhodamine B hexylester was increased in cof1-5 as shown by significant increase of the Pearson colocalisation coefficient. (F–I) Slt2-GFP expression from a plasmid was used to monitor cellular Slt2 localisation in cof1-5 cells in dependence of POR1. Representative microscopy pictures are shown in (F), Slt-GFP foci-containing cells are quantified in (G), cells with nuclear Slt2 are quantified in (H) and the Pearson coefficient of Slt2-GFP colocalization with mitochondria is visualised in (I).

    Journal: iScience

    Article Title: A dynamic actin cytoskeleton is required to prevent constitutive VDAC-dependent MAPK signalling and aberrant lipid homeostasis.

    doi: 10.1016/j.isci.2023.107539

    Figure Lengend Snippet: Figure 5. Slt2 localisation to the mitochondrial compartment is enhanced in cof1-5 cells (A) Slt2, which is mostly found in the nucleus in wild-type cells at stationary phase, forms punctate foci in cof1-5, as documented by fluorescence microscopy using chromosomally tagged SLT2-GFP under control of its endogenous promoter. Deconvolved pictures with Hoechst staining for nuclei are shown. (B and C) Cells showing nuclear localisation of Slt2-GFP (B) and foci-forming cells (C) were quantified, plotted and analyzed for significant localisation change as compared to wild type. (D) Representative fluorescence microscopy pictures of Slt2-GFP expressing cells with rhodamine B hexylester staining for colocalization analysis with mitochondria. (E) Colocalisation of Slt2-GFP (green) with the mitochondrial stain rhodamine B hexylester was increased in cof1-5 as shown by significant increase of the Pearson colocalisation coefficient. (F–I) Slt2-GFP expression from a plasmid was used to monitor cellular Slt2 localisation in cof1-5 cells in dependence of POR1. Representative microscopy pictures are shown in (F), Slt-GFP foci-containing cells are quantified in (G), cells with nuclear Slt2 are quantified in (H) and the Pearson coefficient of Slt2-GFP colocalization with mitochondria is visualised in (I).

    Article Snippet: Immunoblotting followed standard procedures, with transfer of proteins to a 0.45 mm nitrocellulose membrane and probing with 24 iScience 26, 107539, September 15, 2023 antibodies against phospho-Slt2 (Phospho-p44/42 MAPK, cell signaling, #9101, 1:1000), actin (a-Yeast act1 Goat monoclonal antibody, a kind gift from Prof. John Cooper, Washington University, 1:2000), (glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Life Technologies, MA515738, 1:5000), or VDAC/porin (Abcam, ab110326, 1:5000).

    Techniques: Microscopy, Control, Staining, Expressing, Plasmid Preparation

    Figure 6. Reduced actin dynamics lead to a porin-dependent increase in lipid droplet number that are required for CWI activation (A and B) Increase of LD number in cof1-5 depends on Lro1 and Dga1. Mean LD-numbers per cell are plotted in (A) and representative microscopy pictures are shown in (B). Each dot in (A) represents the mean LD number per cell of a single experiment (n = 6) with at least 119 cells being evaluated per experiment. (C and D) Gene deletions of POR1 or SLT2 are sufficient to prevent LD accumulation in cof1-5. Mean LD numbers per cell were assessed by quantifying fluorescence microscopy pictures using Bodipy staining (C). Representative fluorescence microscopy images are shown in (D). (E) Representative EM micrographs supporting the observation of LD-number-increase in cof1-5. V, vacuole; LD, lipid droplet; N, nucleus. Statistical significance in (A) and (C) was assessed using two-way ANOVA with cof1-5 mutation as first factor and additional KO as second factor. See also Figure S4. Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

    Journal: iScience

    Article Title: A dynamic actin cytoskeleton is required to prevent constitutive VDAC-dependent MAPK signalling and aberrant lipid homeostasis.

    doi: 10.1016/j.isci.2023.107539

    Figure Lengend Snippet: Figure 6. Reduced actin dynamics lead to a porin-dependent increase in lipid droplet number that are required for CWI activation (A and B) Increase of LD number in cof1-5 depends on Lro1 and Dga1. Mean LD-numbers per cell are plotted in (A) and representative microscopy pictures are shown in (B). Each dot in (A) represents the mean LD number per cell of a single experiment (n = 6) with at least 119 cells being evaluated per experiment. (C and D) Gene deletions of POR1 or SLT2 are sufficient to prevent LD accumulation in cof1-5. Mean LD numbers per cell were assessed by quantifying fluorescence microscopy pictures using Bodipy staining (C). Representative fluorescence microscopy images are shown in (D). (E) Representative EM micrographs supporting the observation of LD-number-increase in cof1-5. V, vacuole; LD, lipid droplet; N, nucleus. Statistical significance in (A) and (C) was assessed using two-way ANOVA with cof1-5 mutation as first factor and additional KO as second factor. See also Figure S4. Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

    Article Snippet: Immunoblotting followed standard procedures, with transfer of proteins to a 0.45 mm nitrocellulose membrane and probing with 24 iScience 26, 107539, September 15, 2023 antibodies against phospho-Slt2 (Phospho-p44/42 MAPK, cell signaling, #9101, 1:1000), actin (a-Yeast act1 Goat monoclonal antibody, a kind gift from Prof. John Cooper, Washington University, 1:2000), (glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Life Technologies, MA515738, 1:5000), or VDAC/porin (Abcam, ab110326, 1:5000).

    Techniques: Activation Assay, Microscopy, Staining, Mutagenesis

    Figure 7. The acyltransferases Lro1 and Dga1 are required for MAPK-related changes in cof1-5 (A) Polarisation of the actin cytoskeleton was assessed using phalloidin (red) and DAPI (blue) staining. The cof1-5 mutant shows loss of actin polarisation, which is not rescued by gene KO of LRO1, DGA1 or a combined double deletion of the ladder. (B and C) The growth defect (B) and flocculation phenotype (C) as observed in cof1-5 are restored by additional deletion of the acyltransferases LRO1, DGA1, or in the double deletion mutant (lro1D dga1D). (D) Slt2 phosphorylation in cof1-5 depends on Lro1 and Dga1 as the KO of either corresponding gene and the double KO prevents Slt2 phosphorylation. (E) Mean LD abundance per cell was quantified in diverse conditions of stress. 150 cells per condition and experiment were quantified with a total of three independent experiments (n = 3). Statistical significance in (E) was assessed using ordinary one-way ANOVA. Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

    Journal: iScience

    Article Title: A dynamic actin cytoskeleton is required to prevent constitutive VDAC-dependent MAPK signalling and aberrant lipid homeostasis.

    doi: 10.1016/j.isci.2023.107539

    Figure Lengend Snippet: Figure 7. The acyltransferases Lro1 and Dga1 are required for MAPK-related changes in cof1-5 (A) Polarisation of the actin cytoskeleton was assessed using phalloidin (red) and DAPI (blue) staining. The cof1-5 mutant shows loss of actin polarisation, which is not rescued by gene KO of LRO1, DGA1 or a combined double deletion of the ladder. (B and C) The growth defect (B) and flocculation phenotype (C) as observed in cof1-5 are restored by additional deletion of the acyltransferases LRO1, DGA1, or in the double deletion mutant (lro1D dga1D). (D) Slt2 phosphorylation in cof1-5 depends on Lro1 and Dga1 as the KO of either corresponding gene and the double KO prevents Slt2 phosphorylation. (E) Mean LD abundance per cell was quantified in diverse conditions of stress. 150 cells per condition and experiment were quantified with a total of three independent experiments (n = 3). Statistical significance in (E) was assessed using ordinary one-way ANOVA. Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

    Article Snippet: Immunoblotting followed standard procedures, with transfer of proteins to a 0.45 mm nitrocellulose membrane and probing with 24 iScience 26, 107539, September 15, 2023 antibodies against phospho-Slt2 (Phospho-p44/42 MAPK, cell signaling, #9101, 1:1000), actin (a-Yeast act1 Goat monoclonal antibody, a kind gift from Prof. John Cooper, Washington University, 1:2000), (glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Life Technologies, MA515738, 1:5000), or VDAC/porin (Abcam, ab110326, 1:5000).

    Techniques: Staining, Mutagenesis, Phospho-proteomics

    cof1-5 mutation triggers activation of the CWI pathway (A and B) Immunoblots detecting Slt2 phosphorylation when grown on glucose and glycerol containing media are shown in A and B, respectively. (C) Pkc1 inhibition by cercosporamide (CSA) administration prevented Slt2 phosphorylation. (D) Porin deletion and overexpression reveal dependence of Slt2 phosphorylation on Por1. (E) cof1-5 mutation triggers loss of plasma membrane integrity, as assessed flow cytometrically with PI positivity at 48 h after inoculation. PI positivity is exacerbated by additional Pkc1 inhibition using the Pkc1-inhibitor cercosporamide or applying additional cell wall stress with calcofluor white (CFW). Combined treatment with CSA and CFW at the same time shows additive effects. (F) POR1 deletion rescues from cof1-5 -dependent loss of viability and loss of plasma membrane integrity, whereas SLT2 deletion sensitises to cell death. (G–J) Chronological aging analysis reveals shortening of chronological lifespan in cof1-5 cells which depends on POR1 . Colony forming unit formation based on clonogenic survival is depicted in G and H, whereas PI positivity is shown in I and J. Statistical significance in E, F, H, and J was assessed using Brown-Forsythe and Welch-ANOVA test. Asterisks indicate significance based on p-levels of the comparisons to the respective control strains. See also <xref ref-type=Figure S2 . Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. " width="100%" height="100%">

    Journal: iScience

    Article Title: A dynamic actin cytoskeleton is required to prevent constitutive VDAC-dependent MAPK signalling and aberrant lipid homeostasis

    doi: 10.1016/j.isci.2023.107539

    Figure Lengend Snippet: cof1-5 mutation triggers activation of the CWI pathway (A and B) Immunoblots detecting Slt2 phosphorylation when grown on glucose and glycerol containing media are shown in A and B, respectively. (C) Pkc1 inhibition by cercosporamide (CSA) administration prevented Slt2 phosphorylation. (D) Porin deletion and overexpression reveal dependence of Slt2 phosphorylation on Por1. (E) cof1-5 mutation triggers loss of plasma membrane integrity, as assessed flow cytometrically with PI positivity at 48 h after inoculation. PI positivity is exacerbated by additional Pkc1 inhibition using the Pkc1-inhibitor cercosporamide or applying additional cell wall stress with calcofluor white (CFW). Combined treatment with CSA and CFW at the same time shows additive effects. (F) POR1 deletion rescues from cof1-5 -dependent loss of viability and loss of plasma membrane integrity, whereas SLT2 deletion sensitises to cell death. (G–J) Chronological aging analysis reveals shortening of chronological lifespan in cof1-5 cells which depends on POR1 . Colony forming unit formation based on clonogenic survival is depicted in G and H, whereas PI positivity is shown in I and J. Statistical significance in E, F, H, and J was assessed using Brown-Forsythe and Welch-ANOVA test. Asterisks indicate significance based on p-levels of the comparisons to the respective control strains. See also Figure S2 . Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

    Article Snippet: Immunoblotting followed standard procedures, with transfer of proteins to a 0.45 μm nitrocellulose membrane and probing with antibodies against phospho-Slt2 (Phospho-p44/42 MAPK, cell signaling, #9101, 1:1000), actin (α-Yeast act1 Goat monoclonal antibody, a kind gift from Prof. John Cooper, Washington University, 1:2000), (glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Life Technologies, MA515738, 1:5000), or VDAC/porin (Abcam, ab110326, 1:5000).

    Techniques: Mutagenesis, Activation Assay, Western Blot, Phospho-proteomics, Inhibition, Over Expression, Clinical Proteomics, Membrane, Control

    Slt2 localisation to the mitochondrial compartment is enhanced in cof1-5 cells (A) Slt2, which is mostly found in the nucleus in wild-type cells at stationary phase, forms punctate foci in cof1-5 , as documented by fluorescence microscopy using chromosomally tagged SLT2-GFP under control of its endogenous promoter. Deconvolved pictures with Hoechst staining for nuclei are shown. (B and C) Cells showing nuclear localisation of Slt2-GFP (B) and foci-forming cells (C) were quantified, plotted and analyzed for significant localisation change as compared to wild type. (D) Representative fluorescence microscopy pictures of Slt2-GFP expressing cells with rhodamine B hexylester staining for colocalization analysis with mitochondria. (E) Colocalisation of Slt2-GFP (green) with the mitochondrial stain rhodamine B hexylester was increased in cof1-5 as shown by significant increase of the Pearson colocalisation coefficient. (F–I) Slt2-GFP expression from a plasmid was used to monitor cellular Slt2 localisation in cof1-5 cells in dependence of POR1 . Representative microscopy pictures are shown in (F), Slt-GFP foci-containing cells are quantified in (G), cells with nuclear Slt2 are quantified in (H) and the Pearson coefficient of Slt2-GFP colocalization with mitochondria is visualised in (I). (J and K) Expression of Pkc1-GFP under control of its endogenous promoter reveals increased PKC1-GFP foci formation in cof1-5 (J, K). Representative fluorescence microscopy pictures of individual Pkc1-GFP expressing cells with additional rhodamine-B-hexylester staining for mitochondria and autodot staining for LDs are shown in (J) and cells with Pkc1-GFP foci are quantified in (K). (L) The Pearson coefficient was determined as a measure of colocalisation of Pkc1-GFP with mitochondria (rhodamine-B-hexylester). Statistical significance in (B) and (C) was assessed using Welch's t test, (E, K, L) were analyzed using unpaired t test and (G, H, I) by ordinary one-way ANOVA. See also <xref ref-type=Figure S3 . Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. " width="100%" height="100%">

    Journal: iScience

    Article Title: A dynamic actin cytoskeleton is required to prevent constitutive VDAC-dependent MAPK signalling and aberrant lipid homeostasis

    doi: 10.1016/j.isci.2023.107539

    Figure Lengend Snippet: Slt2 localisation to the mitochondrial compartment is enhanced in cof1-5 cells (A) Slt2, which is mostly found in the nucleus in wild-type cells at stationary phase, forms punctate foci in cof1-5 , as documented by fluorescence microscopy using chromosomally tagged SLT2-GFP under control of its endogenous promoter. Deconvolved pictures with Hoechst staining for nuclei are shown. (B and C) Cells showing nuclear localisation of Slt2-GFP (B) and foci-forming cells (C) were quantified, plotted and analyzed for significant localisation change as compared to wild type. (D) Representative fluorescence microscopy pictures of Slt2-GFP expressing cells with rhodamine B hexylester staining for colocalization analysis with mitochondria. (E) Colocalisation of Slt2-GFP (green) with the mitochondrial stain rhodamine B hexylester was increased in cof1-5 as shown by significant increase of the Pearson colocalisation coefficient. (F–I) Slt2-GFP expression from a plasmid was used to monitor cellular Slt2 localisation in cof1-5 cells in dependence of POR1 . Representative microscopy pictures are shown in (F), Slt-GFP foci-containing cells are quantified in (G), cells with nuclear Slt2 are quantified in (H) and the Pearson coefficient of Slt2-GFP colocalization with mitochondria is visualised in (I). (J and K) Expression of Pkc1-GFP under control of its endogenous promoter reveals increased PKC1-GFP foci formation in cof1-5 (J, K). Representative fluorescence microscopy pictures of individual Pkc1-GFP expressing cells with additional rhodamine-B-hexylester staining for mitochondria and autodot staining for LDs are shown in (J) and cells with Pkc1-GFP foci are quantified in (K). (L) The Pearson coefficient was determined as a measure of colocalisation of Pkc1-GFP with mitochondria (rhodamine-B-hexylester). Statistical significance in (B) and (C) was assessed using Welch's t test, (E, K, L) were analyzed using unpaired t test and (G, H, I) by ordinary one-way ANOVA. See also Figure S3 . Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

    Article Snippet: Immunoblotting followed standard procedures, with transfer of proteins to a 0.45 μm nitrocellulose membrane and probing with antibodies against phospho-Slt2 (Phospho-p44/42 MAPK, cell signaling, #9101, 1:1000), actin (α-Yeast act1 Goat monoclonal antibody, a kind gift from Prof. John Cooper, Washington University, 1:2000), (glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Life Technologies, MA515738, 1:5000), or VDAC/porin (Abcam, ab110326, 1:5000).

    Techniques: Fluorescence, Microscopy, Control, Staining, Expressing, Plasmid Preparation

    Reduced actin dynamics lead to a porin-dependent increase in lipid droplet number that are required for CWI activation (A and B) Increase of LD number in cof1-5 depends on Lro1 and Dga1. Mean LD-numbers per cell are plotted in (A) and representative microscopy pictures are shown in (B). Each dot in (A) represents the mean LD number per cell of a single experiment (n = 6) with at least 119 cells being evaluated per experiment. (C and D) Gene deletions of POR1 or SLT2 are sufficient to prevent LD accumulation in cof1-5 . Mean LD numbers per cell were assessed by quantifying fluorescence microscopy pictures using Bodipy staining (C). Representative fluorescence microscopy images are shown in (D). (E) Representative EM micrographs supporting the observation of LD-number-increase in cof1-5 . V, vacuole; LD, lipid droplet; N, nucleus. Statistical significance in (A) and (C) was assessed using two-way ANOVA with cof1-5 mutation as first factor and additional KO as second factor. See also <xref ref-type=Figure S4 . Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. " width="100%" height="100%">

    Journal: iScience

    Article Title: A dynamic actin cytoskeleton is required to prevent constitutive VDAC-dependent MAPK signalling and aberrant lipid homeostasis

    doi: 10.1016/j.isci.2023.107539

    Figure Lengend Snippet: Reduced actin dynamics lead to a porin-dependent increase in lipid droplet number that are required for CWI activation (A and B) Increase of LD number in cof1-5 depends on Lro1 and Dga1. Mean LD-numbers per cell are plotted in (A) and representative microscopy pictures are shown in (B). Each dot in (A) represents the mean LD number per cell of a single experiment (n = 6) with at least 119 cells being evaluated per experiment. (C and D) Gene deletions of POR1 or SLT2 are sufficient to prevent LD accumulation in cof1-5 . Mean LD numbers per cell were assessed by quantifying fluorescence microscopy pictures using Bodipy staining (C). Representative fluorescence microscopy images are shown in (D). (E) Representative EM micrographs supporting the observation of LD-number-increase in cof1-5 . V, vacuole; LD, lipid droplet; N, nucleus. Statistical significance in (A) and (C) was assessed using two-way ANOVA with cof1-5 mutation as first factor and additional KO as second factor. See also Figure S4 . Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

    Article Snippet: Immunoblotting followed standard procedures, with transfer of proteins to a 0.45 μm nitrocellulose membrane and probing with antibodies against phospho-Slt2 (Phospho-p44/42 MAPK, cell signaling, #9101, 1:1000), actin (α-Yeast act1 Goat monoclonal antibody, a kind gift from Prof. John Cooper, Washington University, 1:2000), (glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Life Technologies, MA515738, 1:5000), or VDAC/porin (Abcam, ab110326, 1:5000).

    Techniques: Activation Assay, Microscopy, Fluorescence, Staining, Mutagenesis

    The acyltransferases Lro1 and Dga1 are required for MAPK-related changes in cof1-5 (A) Polarisation of the actin cytoskeleton was assessed using phalloidin (red) and DAPI (blue) staining. The cof1-5 mutant shows loss of actin polarisation, which is not rescued by gene KO of LRO1 , DGA1 or a combined double deletion of the ladder. (B and C) The growth defect (B) and flocculation phenotype (C) as observed in cof1-5 are restored by additional deletion of the acyltransferases LRO1 , DGA1 , or in the double deletion mutant ( lro1 Δ dga1 Δ). (D) Slt2 phosphorylation in cof1-5 depends on Lro1 and Dga1 as the KO of either corresponding gene and the double KO prevents Slt2 phosphorylation. (E) Mean LD abundance per cell was quantified in diverse conditions of stress. 150 cells per condition and experiment were quantified with a total of three independent experiments (n = 3). Statistical significance in (E) was assessed using ordinary one-way ANOVA. Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

    Journal: iScience

    Article Title: A dynamic actin cytoskeleton is required to prevent constitutive VDAC-dependent MAPK signalling and aberrant lipid homeostasis

    doi: 10.1016/j.isci.2023.107539

    Figure Lengend Snippet: The acyltransferases Lro1 and Dga1 are required for MAPK-related changes in cof1-5 (A) Polarisation of the actin cytoskeleton was assessed using phalloidin (red) and DAPI (blue) staining. The cof1-5 mutant shows loss of actin polarisation, which is not rescued by gene KO of LRO1 , DGA1 or a combined double deletion of the ladder. (B and C) The growth defect (B) and flocculation phenotype (C) as observed in cof1-5 are restored by additional deletion of the acyltransferases LRO1 , DGA1 , or in the double deletion mutant ( lro1 Δ dga1 Δ). (D) Slt2 phosphorylation in cof1-5 depends on Lro1 and Dga1 as the KO of either corresponding gene and the double KO prevents Slt2 phosphorylation. (E) Mean LD abundance per cell was quantified in diverse conditions of stress. 150 cells per condition and experiment were quantified with a total of three independent experiments (n = 3). Statistical significance in (E) was assessed using ordinary one-way ANOVA. Error bars indicate standard error of the mean (SEM) and asterisks indicate significant differences based on p-values, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

    Article Snippet: Immunoblotting followed standard procedures, with transfer of proteins to a 0.45 μm nitrocellulose membrane and probing with antibodies against phospho-Slt2 (Phospho-p44/42 MAPK, cell signaling, #9101, 1:1000), actin (α-Yeast act1 Goat monoclonal antibody, a kind gift from Prof. John Cooper, Washington University, 1:2000), (glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Life Technologies, MA515738, 1:5000), or VDAC/porin (Abcam, ab110326, 1:5000).

    Techniques: Staining, Mutagenesis, Flocculation, Phospho-proteomics

    Journal: iScience

    Article Title: A dynamic actin cytoskeleton is required to prevent constitutive VDAC-dependent MAPK signalling and aberrant lipid homeostasis

    doi: 10.1016/j.isci.2023.107539

    Figure Lengend Snippet:

    Article Snippet: Immunoblotting followed standard procedures, with transfer of proteins to a 0.45 μm nitrocellulose membrane and probing with antibodies against phospho-Slt2 (Phospho-p44/42 MAPK, cell signaling, #9101, 1:1000), actin (α-Yeast act1 Goat monoclonal antibody, a kind gift from Prof. John Cooper, Washington University, 1:2000), (glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Life Technologies, MA515738, 1:5000), or VDAC/porin (Abcam, ab110326, 1:5000).

    Techniques: Virus, Recombinant, Microarray, High Performance Thin Layer Chromatography, Software